Orphan designation: nanatinostat,valganciclovir Treatment of peripheral T-cell lymphoma, 10/08/2022 Withdrawn | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 4 September 2025 - 11:08

Orphan designation: nanatinostat,valganciclovir Treatment of peripheral T-cell lymphoma, 10/08/2022 Withdrawn

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-22-2673

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters